Presentations and Abstracts

Merlin T, Carter D, Kessels S. Toward a framework for assessing ethical considerations relating to genetic tests. Health Technology Assessment international (HTAi) 2023 Annual Meeting. Adelaide, Australia, June 24-28 2023.

Gao Y, Laka M, Merlin T. Road to Public Funding of Cancer Co-dependent Technologies - A 10year review in Australia. Oral presentation*, Health Technology Assessment international (HTAi) 2023 Annual Meeting. Adelaide, Australia, June 24-28 2023.

Gao Y, Laka M, Merlin TL. Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia. Poster Presentation*, Health Technology Assessment international (HTAi) 2022 Annual Meeting. Utrecht, Netherlands, June 25-29 2022.

Laka M, Carter D, Merlin TL. Gaps in the evaluation of clinical decision support software (CDSS): Interviews with Australian policymakers. Health Technology Assessment international (HTAi) 2022 Annual Meeting. Utrecht, Netherlands, June 25-29 2022.

Hillock N, Chen G, Turnidge J, Louise J, Merlin T, Karnon J. Is it worth the money? Healthcare practitioners' willingness to pay for narrow spectrum and other attributes of antimicrobials. Poster Presentation*, 32nd International Congress of antimicrobial Chemotherapy (ICC). Perth Australia, November 27-30 2022.

Hillock N, Connor E, Chen G, Turnidge J, Louise J, Merlin T, Karnon J. NAUSP methodology updates and application of the priority antibacterial list in Australian acute care hospitals, 2019-21. Poster Presentation*, 32nd International Congress of antimicrobial Chemotherapy (ICC). Perth Australia, November 27-30 2022.

Lopes McInnes E, Stafinski T, Carter D, Merlin T, & Street J. Stakeholders' Perspectives on Public Involvement in Health Technology Assessment in Canada. Health Technology Assessment International (HTAi) 2021 Annual Meeting. Manchester, United Kingdom, June 19-23 2021.

Laka M, Milazzo A, & Merlin T. Why provision of clinical decision support (CDS) is not enough? Factors influencing the CDS adoption. Poster Presentation*, Meeting of EUROPEAN JOURNAL OF PUBLIC HEALTH. OXFORD UNIV PRESS.

Newton S, Kessels S, Vogan A, Merlin T. Shift From Regional to Federal Funding: Methodological Considerations. Poster presentation*, XVI Annual Meeting HTAi 2019. Cologne, Germany, 17-19 June 2019.

Moshi M, Tooher R, Merlin T. Assessment of mHealth apps: is current regulation policy adequate? Oral presentation*, XVI Annual Meeting HTAi 2019. Cologne, Germany, 17-19 June 2019.

Moshi M, Tooher R, Merlin T. mHealth app evaluation framework for reimbursement decision-making. Oral presentation*, XVI Annual Meeting HTAi 2019, Cologne, Germany, 17-19 June 2019.

Kessels S, Newton S, Vogan A, Merlin T. Shift from regional to federal funding: methodological considerations. Poster presentation*, XVI Annual Meeting HTAi 2019, Cologne, Germany, 17-19 June 2019.

Merlin T, O'Rourke, Van der Wilt GJ, Lampe K. Defining HTA: How to develop a common understanding and consensus on the language and methods of HTA. Panel presentation*. XVI Annual Meeting HTAi 2019. Cologne, Germany, 17-19 June 2019.

Scott NA, Moga C, Bekkering T, Merlin T. Cutting corners not rigor: using rapid review techniques in guideline development. Workshop presentation*. XVI Annual Meeting HTAi 2019, Cologne, Germany, 17-19 June 2019.

Laka M, Milazzo A, Merlin T. 2019. 'Sustainable implementation of electronic decision support tools for the evidence-based management of antibiotics'. DPH2019: Proceedings of the 9th International Conference on Digital Public Health, November 2019, pages 7-8.

Hillock N, Turnidge J, Karnon J, Merlin T. Policy Incentives for sustainable antibiotic market: the perspective of Australian stakeholders - a qualitative study. Poster presentation*, Australian Society for Antimicrobials 2019. Sydney, Australia, 21-23 February 2019.

Hillock N, Paradiso L, Turnidge J, Karnon J, Merlin T. Special access scheme category C and antimicrobial drugs - a policy solution or a temporary fix?. Poster presentation*, Australian Society for Antimicrobials 2019. Sydney, Australia, 21-23 February 2019.

Carter D, Vogan A, Merlin T. The need for ethics committees and evaluation agencies in coverage with evidence development: the case of crizotinib in Australia. Oral presentation*. Australasian Association of Bioethics and Health Law Conference. Townsville, Australia, 23-25 September 2018.

Hillock N, Merlin T, Turnidge J, Karnon J. Antimicrobial drugs and the Special Access Scheme: an anomaly or a marker of a system in crisis? Lightning presentation*. National Medicines Symposium. Canberra, Australia, 31 May 2018.

Kessels S, Newton S, Carter D, Merlin T. The Effectiveness and Ethics of Prenatal Testing for Cystic Fibrosis. Vignette presentation*. XV Annual Meeting, Health Technology Assessment international (HTAi), Vancouver, Canada, 1-5 June 2018.

Milverton J, Newton S, Vogan A, Schubert C, Merlin T. Methodology to assess a predictive test for breast cancer recurrence. Poster session*. XV Annual Meeting, Health Technology Assessment international (HTAi). Vancouver, Canada, 1-5 June 2018.

Vogan A, Schubert C, Newton S, Merlin T. What are we missing by limiting the outcome of cost effectiveness analyses of diagnostic tests to cost per correct result? Poster presentation* XV Annual Meeting, Health Technology Assessment international (HTAi). Vancouver, Canada, 1-5 June 2018.

Strachan L, Lewis S, Merlin TL. The Value-based Health Care Movement – What Role Does HTA Play?. Panel presentation*. XV Annual Meeting, Health Technology Assessment international (HTAi). Vancouver, Canada, 1-5 June 2018.

Merlin TL, Belorgey C, Mejia A, McCabe C, Kim S. Promise or compromise? The value of RWE in HTA: INAHTA members’ experiences. Panel presentation*. XV Annual Meeting, Health Technology Assessment international (HTAi). Vancouver, Canada, 1-5 June 2018.

Freeman-Robinson MK, Merlin TL, Mihalopoulos C, Roughead E. Securing access to medicines using discounts in Australia. Poster session*. XV Annual Meeting, Health Technology Assessment international (HTAi). Vancouver, Canada, 1-5 June 2018.

Freeman-Robinson MK, Mihalopoulos C, Merlin TL, Roughead E. Decision criteria that influence managed entry agreements. Poster session*. XV Annual Meeting, Health Technology Assessment international (HTAi). Vancouver, Canada, 1-5 June 2018.

Kip M, Jzerman M, Henriksson M, Merlin T, Weinstein M, Phelps C, Kusters R, Koffijberg H. Towards AliGnment in the reporting of economic evaluations of diagnostic tests and biomarkers: the AGREEDT checklist. Poster Presentation *, Methods for Evaluation of medical prediction Models, Tests and Biomarkers (MENTAB) 2018 Symposium. Utrecht, Netherlands, 2-3 July 2018.

Moshi M, Parsons J, Tooher R, Merlin T. Assessment of mHealth apps: is current regulation adequate?. Poster Presentation* 12th annual Florey postgraduate research conference. Adelaide, Australia, 25 September 2018.

Moshi M, Parsons J, Tooher R, Merlin T. Suitable frameworks for mHealth app evaluation in Australian healthcare reimbursement. Rapid Fire Presentation and Poster Presentation* The Annual Scientific Meeting of the Australasian Epidemiological Association. Freemantle, Australia, 22-24 October 2018.

Moshi M, Parsons J, Tooher R, Merlin T. Assessment of mHealth apps: is current regulation policy adequate? Poster Presentation*  South Australian Population Health Conference. Adelaide, Australia, 1 December 2018.

Vogan A, Schubert C, Merlin T. The impact of treatment timing on the cost-effectiveness of tests. Vignette presentation*. XIV Annual Meeting, Health Technology Assessment international (HTAi), Rome, Italy, 17-21 June 2017.

Merlin T, Hiller JE, Ryan P. Does HTA methodology affect the decision to fund medical tests? Vignette presentation*. XIV Annual meeting, Health Technology Assessment international (HTAi), Rome, Italy, 17-21 June 2017.

Hausner E, Merlin T, O'Rourke B, Chalon P, Mejia A, Waffenschmidt S. Rescuing the HTA database - future options and challenges. Panel presentation*. XIV Annual Meeting, Health Technology Assessment international (HTAi), Rome, Italy, 17-21 June 2017.

Carter D, Merlin T, Hunter D. Coercing or inducing patients to participate in evidence generation. Australasian Association of Philosophy Conference. Adelaide, 2 July 2017.

Hillock N, Turnidge J, Karnon J, Merlin T. Investigating the utilisation of unregistered antimicrobial drugs in Australia. Poster Presentation* 11th annual Florey postgraduate research conference. Adelaide, Australia, 2018.

Vogan A, Schubert C, Newton S, Merlin T. What are we missing by limiting the outcome of cost effectiveness analyses of diagnostic tests to cost per correct result?. Poster presentation*. XIII Annual Meeting, Health Technology Assessment international (HTAi), Tokyo, 10-14 May 2016.

Parsons J, Newton S, Merlin T. Can lack of clinical utility be used as reason for disinvestment of investigative tests?. Poster presentation*. XIII Annual Meeting, Health Technology Assessment international (HTAi), Tokyo, 10-14 May 2016.

Schubert C, Newton S, Merlin T. Assessing value-for-money for orphan drugs; the mismatch of applied methods, economic theory and available data. Oral presentation*. XIII Annual Meeting, Health Technology Assessment international (HTAi), Tokyo, 10-14 May 2016.

Merlin T, Mujoomdar M, Ahn J, Dedeu I, Baraldes T. Getting a grip on new technologies: INAHTA member agency experiences with m-health, apps, telehealth, and other point-of-care-technologies. Panel presentation*. XIII Annual Meeting, Health Technology Assessment international (HTAi), Tokyo, Japan, 10-14 May 2016.

Merlin T, Panteli D, Espin J, Lepanto L, Ramsay C. HTA in academic curricula: demand, experience, ways forward and potential for collaboration. Workshop. XIII Annual Meeting, Health Technology Assessment international (HTAi), Tokyo, Japan, 10-14 May 2016.

Moshi M, Tooher R, Merlin T. Determining the feasibility of reimbursing mobile health apps in Australia. Poster Presentation* Public Health Association of Australia 44th Annual and 20th Chronic Diseases Network Conference, Alice Springs, Australia, 18-21 September 2016.

Merlin T. HTA for companion diagnostics: different models and best practices to make it possible. Invited presentation*. European Diagnostic Manufacturers Association (EDMA), Brussels, Belgium, 11 June 2015.

Lopes do Carmo E, Street J, Carter D, Merlin T. Stakeholders views on Australian public and patient involvement in HTA. Oral presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, Norway, 13-17 June 2015.

Merlin T (Panel coordinator and speaker), Mujoomdar M, Kisser A, Wurcel V. Living in testing times: translating evidence on medical tests and companion diagnostics into reimbursement decisions. Panel presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, Norway, 13-17 June 2015.

Vogan A, Mitchell A, Tamblyn D & Merlin T. Managed entry schemes: enabling access to oncology drugs under uncertainty. Poster presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, 13-17 June 2015.

Kessels S, Morona J, Newton S & Merlin T. The impact of an imperfect reference standard. Poster presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, Norway, 13-17 June 2015.

Pridham L, Liufu Z, Newton S & Merlin T. International comparison of subsidisation of drugs for rare diseases and the definitions for rare/ultra-rare disease. Poster presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, 13-17 June 2015.

Morona J, Newton S & Merlin T. Meta-analysis of two tests via a common reference standard for detection of Tuberculosis infections. Poster presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, Norway, 13-17 June 2015.

Vogan A, Schubert C, Parsons J, Morona J & Merlin T. The impact of an imperfect diagnostic reference standard on the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes. Oral presentation*.11th Annual Meeting, Health Technology Assessment international (HTAi), Washington DC, 16-18 June 2014.

Kessels S, Schubert C, Newton S & Merlin T. Assessment of catheter-free (wireless)ambulatory oesophageal pH monitoring for Gastroesophageal Reflux Disease (GORD). Poster presentation*. 11th Annual Meeting, Health Technology Assessment international (HTAi), Washington DC, 16-18 June 2014.

Newton S, Milverton J & Kessels, S. Technology to assist with guideline development: software for systematic reviews. Oral presentation*. 11th G-I-N Conference, Melbourne, 20-23 August 2014.

Milverton J, Ellery B, Newton S, Kessels S, Gum D & Merlin T. CT colonography for those at high risk or symptomatic for colorectal cancer. Poster/Oral presentation*. 11th G-I-N Conference, Melbourne, 20-23 August 2014.

Vogan A, Schubert C, Parsons J, Morona J & Merlin T. Assessing the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes and the impact of an imperfect diagnostic reference standard. Poster presentation*. 36th Annual Meeting of the Society for Medical Decision Making, Miami, 22 October 2014.

Merlin T, Schubert C. Evaluating medical tests for coverage decisions using the linked evidence approach. Pre-conference workshop*. 11th Annual meeting, Health Technology Assessment international (HTAi), Washington DC, 15 June 2014.

Merlin T. Standardising health technology assessment to enhance transferability across jurisdictions and nations: the first step towards a solution. Poster Presentation*3rd Health Technology Assessment Conference, Sydney, Australia, 24-25 November 2014.

Merlin T. Two by two - a methodological perspective on the use of evidence to support the value of a health care technology. Poster Presentation* New Zealand Health Care Congress, Auckland, New Zealand. 2014.

Newton S, Wang S, Schubert, Merlin T. One small step for an individual, one giant leap for their family: considerations required for assessing the cost-effectiveness of genetic tests. Oral presentation*. 10th HTAi 2013, Seoul, South Korea, 15-19 June 2013.

Newton S, Fitzgerald P, Merlin T. Mutation testing of the RET gene got MEN2. Poster presentation*. 10th HTAi 2013, Seoul, South Korea, 15-19 June 2013.

Morona J, Newton S, Ellery B, Merlin T. Genetic testing for VHL disease: limited benefit to the individual, but reduced surveillance for family members. Poster presentation*. 10th HTAi 2013, Seoul, South Korea, 15-19 June 2013.

Haji Ali Afzali H, Karnon J, Merlin T. Improving the accuracy and comparability of model-based economic evaluations of health technologies for reimbursement decisions: a methodological framework for the development of reference models. Poster Presentation*10th HTAi 2013, Seoul, South Korea, 15-19 June 2013.

Merlin T, Ellery B, Juneja V, Tamblyn D. What's in a name? - mapping the different HTA products of INAHTA members. Oral presentation*. 10th HTAi 2013, Seoul, South Korea, 15-19 June 2013.

Morona J, Buckley E, Reddin E, and Merlin T. The use of growth factors to promote healing of diabetic foot ulcers: A Systematic Review.  Poster presentation*.2013 Australasian Cochrane Symposium, Melbourne, Australia, 20-21 November 2013.

Lopes do Carmo E, Street J M, Carter DA, Merlin TL. Excluding patient and citizen voices from health-care funding decision-making: what is the public health impact? Public Health Association of Australia (PHAA) 42nd Annual Conference. Melbourne, Australia, 16-18 September 2013.

Moshi M, Tamblyn D, Merlin T. Rise of Co- dependent Technologies: Surveying stakeholders about their opinion on the co-dependent technology framework and decision-making process. Poster Presentation* SA State Population Health Conference. Adelaide, Australia, 2013.

Street J, Marciano N, Merlin T, Bessen T. How good is the guidance for cutaneous melanoma follow-up? A systematic review of clinical practice guidelines. Poster Presentation* FCIC Survivorship Conference. Adelaide, Australia, 2013.

Merlin T. Coverage with evidence development: when is it appropriate? Poster Presentation* ARCS Health Economics Conference. Canberra, Australia, 2013.

Merlin T. Impact of Health Technology Assessment – AHTA’s perspective. International Network of Agencies for Health Technology Assessment Annual Meeting. Bilbao, Spain. June 28, 2012.

Merlin T, Farah C, Schubert C, Mitchell A, Hiller JE, Ryan P. How to assess personalised medicines for reimbursement decisions? Developing a framework for Australia. Oral presentation*. IX Annual Meeting HTAi 2012. Bilbao, Spain, 25-27 June 2012.

Merlin T, Street J. Keeping an eye on the problem: developing a disinvestment methodology to review Australian medical services – ‘ophthalmology’ as a test case. Oral presentation*. IX Annual Meeting HTAi 2012. Bilbao, Spain, 25-27 June 2012.

Merlin T. Examining the challenges of health technology assessment from personalised medicine: the need for innovative approaches. Poster Presentation* 1st Health Technology Assessment Conference. Sydney, Australia 2013.

Merlin T. Challenges for independent evaluation: MSAC assessments – past, present and future. ARCS Scientific Congress, National Convention Centre. Canberra, Australia, 2 August, 2011.

Merlin T. Feasibility of the linked evidence approach when assessing diagnostic tests for public funding. Screening and Test Evaluation Program (STEP) Seminar, University of Sydney. Sydney, Australia, 16 March, 2011.

Hennessy S, Street J, Scrimgeour S & Merlin T. A rapid review of patient perspectives on cataract surgery collected using peer-reviewed literature and personal blogs: a comparison with patient interviews. Oral presentation*.HSRAANZ Health services and policy research conference. Adelaide, Australia, 5-7 December, 2011.

Merlin T. The FORM grading method: advantages and challenges. Poster Presentation* National Health and Medical Research Council Guidelines Development Symposium. Melbourne, Australia, 2011.

Merlin T, Lehman S. The benefits and flaws of the Linked Evidence Approach (LEA) to assess diagnostic and screening tests. Poster presentation*. 7th Annual Meeting, Health Technology Assessment international (HTAi). Dublin, Ireland, 6-9 June, 2010.

Merlin T, Liufu Z & Wang S. Unattended sleep studies in the diagnosis of obstructive sleep apnoea. Poster presentation*. 7th Annual Meeting, Health Technology Assessment international (HTAi). Dublin, Ireland, 6-9 June, 2010.

Buckley E, Wang S, Merlin T & Hiller JE. Use of disease prevalence when estimating the positive predictive value of a test can mislead: the spectrum effect. Poster presentation*. 7th Annual Meeting, Health Technology Assessment international (HTAi). Dublin, Ireland, 6-9 June, 2010.

Buckley E, Merlin T, Mundy L & Hiller JE. Molecular testing for myeloproliferative disease: The conundrum of an imperfect reference standard. Poster presentation*. 7th Annual Meeting, Health Technology Assessment international (HTAi). Dublin, Ireland, 6-9 June, 2010.

Penner A, Mundy L & Hiller JE. M5-03 Horizon scanning for new and emerging health technologies in Australia: Does it address the Australian national health priority areas. 7th Annual Meeting, Health Technology Assessment international (HTAi). Dublin, Ireland, 6-9 June, 2010. Page 170.

Mundy L, Watt, A & Hiller JE. Direct-to-consumer marketing in Australia: Health Technology Assessment missing in action. Oral presentation*. 40th Annual Conference, Public Health Association of Australia (PHAA). Adelaide, Australia, 27-29 September, 2010.

Mundy L, Hiller JE. HT1. Early alert systems for new pharmaceuticals - do they have an impact on pharmaceutical reimbursement decisions: a cross - national Comparison. 4th Asia-Pacific Conference, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Phuket, Thailand, 2-7 September, 2010. Page 62.

Merlin T. Rationale for proposed description of evidence needs. Poster Presentation* ARCS Scientific Congress. Canberra, Australia, 2010.

Merlin T. Developing a framework for co-dependent technologies for reimbursement. Poster Presentation* Test Evaluation Symposium, NHMRC Clinical Trials Centre and Screening and Test Evaluation Program (STEP). Sydney, Australia, 2010.

Merlin T. Personalised medicine initiatives. Poster Presentation* Evidence-based Pathology Seminar, The Royal College of Pathologists of Australasia. Sydney, Australia, 2010.

Mundy L, Merlin T & Hiller JE. Early alert systems for new pharmaceuticals - do they have an impact on pharmaceutical public reimbursement decisions?: A cross-national comparison Globalisation and Health Technology Assessment Poster Presentation*. 6th Annual Meeting, Health Technology Assessment international (HTAi). Singapore, 21-24 June, 2009.

Elshaug AG. Reallocating Resources in Health Care Systems: The Role of HTA Units in Identifying Existing Technologies of Low Added Value. Presenter and Chair of panel session*. 6th Annual Meeting, Health Technology Assessment international (HTAi). Singapore, 21-24 June, 2009.

Newton S, Street J, Merlin T & Hiller JE. Is MRI effective for staging newly diagnosed rectal carcinoma? That depends on whether it changes management. Oral presentation*. 6th Annual Meeting, Health Technology Assessment international (HTAi). Singapore, 21-24 June, 2009.

Ju H, Newton S, Merlin T & Hiller JE. Quality assessment of clinical practice guidelines (CPGs): Is ADAPTE adaptable? Poster presentation*. 6th Annual meeting, Health Technology Assessment international (HTAi). Singapore, 21-24 June, 2009.

Wang S, Gum D, Merlin T & Hiller JE. Predictors of vaccination uptake and course completion: A systematic review. Poster presentation. 6th Annual Meeting, Health Technology Assessment international (HTAi). Singapore, 21-24 June, 2009.

Elshaug AG. Guideline development for Disinvestment. Osteba Multi-Sector Disinvestment Workshop. Bilbao, Spain, 12-14 May 2009.

Elshaug AG. Does Surgery Have a role in the Treatment of OSA? A Health Policy Perspective. 3rd International Symposium on Surgery, Sleep and Breathing. International Surgical Sleep Society. Amsterdam, Netherlands, 8-9 May, 2009.

Elshaug AG. Assessment of Clinical Utility and Implementation of Change. Annual Scientific Education Symposium, Australasian Association of Clinical Biochemists (AACB). Adelaide, Australia, 1 May, 2009.

Kreisz FP, Merlin T, Hiller JE & Gericke C. The cost-utility of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease. Poster presentation*. 7th European Conference on Health Economics. Rome, Italy, 23-26 July, 2008.

Elshaug AG. International perspectives on disinvestment from ineffective health care practices. Oral presentation*. 5th Annual Meeting, Health Technology Assessment international (HTAi). Montreal, Canada, July 6-9, 2008.

Elshaug AG. Disinvestment from existing ineffective health care practices. Introducing innovation in Healthcare Systems. EuroScan and Osteba Conference. Bilbao,
Spain, April 2-4, 2008.

Kreisz FP, Merlin T, Atherton J, Hiller J, Gericke C. The pre-test risk stratified cost-effectiveness of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease. Oral presentation*. 5th Annual Meeting Health Technology Assessment international (HTAi). Montreal, Canada,6-9 July, 2008.

Merlin TL, Moss J, Hiller JE. Location, location, location - the impact of health care setting of technology use on both HTA results and funding policy. Poster presentation*. 5th Annual Meeting, Health Technology Assessment international (HTAi). Montreal, Canada 6-9 July, 2008.

Merlin TL, Newton S, Wang S, Hiller J. Technology assessment in the context of workforce shortages and changing supply: Digital mammography. Oral presentation*. 5th Annual Meeting, Health Technology Assessment international (HTAi). Montreal, Canada, 6-9 July, 2008.

Wang S, Merlin T, Kreisz F, Craft P, Hiller JE, Cost-effectiveness of digital mammography compared with film-screen mammography in Australia. Poster presentation*. Population Health Congress. Brisbane, Australia, 6-9 July, 2008.

Elshaug AG, Hiller JE & Moss JR. Exploring Policymakers' Perspective on Disinvestment from Ineffective Health Care Practices. 5th Health Services Research Association of Australia and New Zealand (HSRAANZ) conference. Auckland, New Zealand 2-5 December, 2007.

Elshaug AG, Hiller JE & Moss JR. Disinvestment from Ineffective Health care Practices: An Exploration of Policymakers' Perspectives. The Menzies centre for health Policy, Emerging Health Policy Research Conference. Canberra, Australia, 12 October, 2007. 
 
Ivan M, Merlin T, Hiller JE, Newton S, Sullivan T, Buckley L & Hedayati H. Multi-slice computed tomography or conventional coronary angiography - how a systematic review of safety and effectiveness can inform decision-making. Oral Presentation*. State Population Health conference. Adelaide, Australia, 20 October, 2007.

Hiller JE, Moyes L, Mundy L & Merlin T. Horizon scanning for public health interventions. 4th Annual Meeting Health Technology Assessment international (HTAi). Barcelona, Spain, 17 -20 June, 2007. Book of Abstracts pp. 93.

Banham D, Merlin T, Woollacott T. Evaluating overweight/obesity health promotion activities on multiple criteria (of effectiveness, efficiency and equity). Oral presentation*. Australian Health Promotion Association's 17th National Conference. Adelaide, Australia, 1-4 May, 2007.

Elshaug AG, Hiller JE, Southcott AM & Moss JR. An Audit of Surgical Intervention for Obstructive Sleep Apnoea: Questions of Efficacy and Improved Health Outcomes. Oral Presentation*. 3rd Annual Meeting, Health Technology Assessment international (HTAi). Adelaide, Australia, 3-5 July, 2006.

Elshaug AG, Hiller JE, Southcott AM & Moss JR. When clinical practices vary, best practice is one of multiple variations: a practical analysis of the know-do-gap. Canadian Association for Health Services and Policy Research (CAHSPR) annual conference. Vancouver, Canada, 17-19 September, 2006. p.53.

Elshaug AG, Hiller JE, Southcott AM & Moss JR. When clinical practices vary, best practice is one of multiple variations: need for a formal mechanism to monitor effectiveness. The 6th International Conference on Priorities in health Care. Toronto, Canada, 20-22 September, 2006.

Elshaug AG, Moss JR & Hiller JE. Inverse care law: a micro level example in Australia. International Society for Equity in Health (ISEqH) 4th Biennial International Conference. Adelaide, Australia,11-13 September, 2006.

McCaffrey N, Merlin T & Hiller J. Lack of clinical rationale provided for non-inferiority margins. Poster presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi). Adelaide, Australia, 3-5 July, 2006.
 
Merlin T, Newton S, Thomson K & Hiller JE. Brittle bones and painful backs: a systematic review of the safety and effectiveness of vertebroplasty. Poster presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi). Adelaide, Australia, 3-5 July, 2006.

Merlin T, Brooks A, Lord S & Hiller JE. How to assess the effectiveness of a triage test in the context of direct versus linked evidence? Poster Presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi). Adelaide, Australia, 3-5 July, 2006.

Mundy L, Merlin T, Sullivan T & Hiller JE. Determining the fate of a health technology: why some technologies don't get off first base. Poster presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi). Adelaide, Australia, 3-5 July, 2006.

Newton S, Merlin T, Forbes D, Phelps A, Creamer M & Hiller J. Challenges in updating evidence-based clinical practice guidelines. Oral presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi). Adelaide, Australia, 3-5 July, 2006.

Newton S, Merlin T, Hedayati H, Thomson K & Hiller J. Kyphoplasty for treating vertebral compression fractures with kyphosis. Poster presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi). Adelaide, Australia, 3-5 July, 2006.

Sullivan T, Merlin T, Mundy L & Hiller JE. Horizon scanning activity as a marker for changing patterns in medical research. Oral presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi). Adelaide, Australia, 3-5 July, 2006.

Elshaug AG, Hiller JE & Moss JR. When clinical practices vary, best practice is only one of multiple variations: need for a formal mechanism to monitor effectiveness. 4th Health Services and Policy Research Conference (Health Services Research Association of Australia and New Zealand). Canberra, Australia,13-16 November 2005.

Merlin T, Middleton P, Salisbury J & Weston A. Ways to ensure evidence-based clinical practice guidelines are of high quality. Discussion workshop*. XII Cochrane Colloquium. Melbourne, Australia, 22-26 October 2005. W52, p196.

Merlin T, Weston A, Tooher R & (NHMRC "Levels" Working Party). Re-assessing and revising "levels of evidence" in the critical appraisal process. Oral presentation*. XIII Cochrane Colloquium. Melbourne, Australia, 22-26 October 2005. O32, p. 9.49.

Merlin T, Hodgkinson B, Moss J & Hiller JE. Economic analysis within a health technology assessment: practical issues. Italian Journal of Public Health (Supplement 1), Summer 2005, Year 3, 2(2): 262. Poster presentation*. Bringing HTA into practice, 2nd Annual Meeting. Rome, Italy, 20-22 June, 2005.

Mundy L, Merlin T, Parrella A & Hiller JE. The Australian horizon scanning network. Italian Journal of Public Health (Supplement 1), Summer 2005, Year 3 2(2): 163. Oral presentation*. Bringing HTA into practice, 2nd Annual Meeting. Rome, Italy, 20-22 June, 2005.

Merlin T, Weston A & Tooher R. Revising a national standard: redevelopment of the Australian NHMRC evidence hierarchy. Italian Journal of Public Health (Supplement 1), Summer 2005, Year 3, 2(2): 156 Oral presentation*. Bringing HTA into practice, 2nd Annual Meeting. Rome, Italy, 20-22 June, 2005.

Hodgkinson B, Moss J, Merlin T & Hiller JE. Economic analysis within a health technology assessment: practical issues. Oral presentation*. Regional Conference on Cost Effective Healthcare. Singapore, 22-23 October, 2004.

Merlin TL, Hiller JE. Are institutionalised approaches to pain assessment and management effective? A systematic review. Poster presentation*. 1st Annual Meeting, Health Technology Assessment international (HTAi). Krakow, Poland, 20 May - 2 June, 2004.

Merlin TL, Mundy L & Hiller JE. Caught between a rock and a hard place: indirect comparisons and the trade-off between information and methodological rigour. Poster presentation*. 1st Annual Meeting, Health Technology Assessment international (HTAi). Krakow, Poland, 30 May - 2 June, 2004.

Merlin TL, Hiller JE, Babidge W, McConnell A & Kearney B. The development of the Australia and New Zealand Horizon Scanning Network and its impact on policy. Oral presentation*. 1st Annual Meeting, Health Technology Assessment international (HTAi). Krakow, Poland, 30 May - 2 June, 2004.

Merlin TL. Indirect comparisons (Workshop 2 - Methods: Therapy). Oral presentation*. MSAC Evaluator's Meeting. Melbourne, Australia, 20 November, 2003.

Merlin TL, Hiller JE. Are institutionalised approaches to pain assessment and management effective? A systematic review. Poster presentation*. Health Services Research Association of Australia and New Zealand Conference. Melbourne, Australia, 16-19 November, 2003.

Hodgkinson B, Moss J, Merlin TL & Hiller JE. When the comparator is 'usual care': an example from osteoarthritis of the knee. Oral presentation*. 19th Annual Meeting, International Society of Technology Assessment in Health Care. Canmore, Canada, 22-25 June, 2003.

Merlin TL, Mundy L, Dekker GA & Hiller JE. Antenatal screening for heritable thrombophilia: Is public funding merited? Poster presentation*. 19th Annual Meeting, International Society of Technology Assessment in Health Care. Canmore, Canada, 22-25 June, 2003.

Merlin TL, Mundy L, Dekker G & Hiller JE. Antenatal screening for heritable thrombophilia: what is the evidence? Oral presentation*. Perinatal Society of Australia and New Zealand Congress. Hobart, Australia, March, 2003.

Merlin TL. Laparoscopic live donor nephrectomy. Poster Presentation* British Journal of Surgery. Melbourne, Australia, 2003.

Hiller JE, Merlin T, Mundy L & Hodgkinson B. What is MSAC and what do we do for them? Oral presentation*. Department of Public Health, University of Adelaide. Adelaide, Australia, September, 2002.

Merlin T. Methodological considerations in a surgical systematic review. Oral presentation*. Cochrane Non-Randomised Studies Methods Group meeting. Oxford, United Kingdom, July, 2002.

Merlin T. What access method is the safest and most effective at establishing pneumoperitoneum in laparoscopic surgery? A systematic review. Oral presentation. Department of Public Health, University of Adelaide. Adelaide, Australia, October, 2001.

Merlin T. Tension-free urethropexy: intravaginal slingplasty and the tension-free vaginal tape procedures. Poster Presentations* Australasian Scientific Congress, Royal Australasian College of Surgeons. Canberra, Australian, 2001.